| Literature DB >> 31351884 |
Craig A Elmets1, Henry W Lim2, Benjamin Stoff3, Cody Connor1, Kelly M Cordoro4, Mark Lebwohl5, April W Armstrong6, Dawn M R Davis7, Boni E Elewski1, Joel M Gelfand8, Kenneth B Gordon9, Alice B Gottlieb10, Daniel H Kaplan11, Arthur Kavanaugh12, Matthew Kiselica13, Dario Kivelevitch14, Neil J Korman15, Daniela Kroshinsky16, Craig L Leonardi17, Jason Lichten13, Nehal N Mehta18, Amy S Paller19, Sylvia L Parra20, Arun L Pathy21, Elizabeth A Farley Prater22, Reena N Rupani5, Michael Siegel13, Bruce E Strober23, Emily B Wong24, Jashin J Wu25, Vidhya Hariharan26, Alan Menter14.
Abstract
Psoriasis is a chronic inflammatory disease involving multiple organ systems and affecting approximately 3.2% of the world's population. In this section of the guidelines of care for psoriasis, we will focus the discussion on ultraviolet (UV) light-based therapies, which include narrowband and broadband UVB, UVA in conjunction with photosensitizing agents, targeted UVB treatments such as with an excimer laser, and several other modalities and variations of these core phototherapies, including newer applications of pulsed dye lasers, intense pulse light, and light-emitting electrodes. We will provide an in-depth, evidence-based discussion of efficacy and safety for each treatment modality and provide recommendations and guidance for the use of these therapies alone or in conjunction with other topical and/or systemic psoriasis treatments.Entities:
Keywords: Goeckerman; PUVA (topical; bath; climatotherapy; grenz ray; intense pulsed dye laser; narrowband ultraviolet light A (NB-UVA); narrowband ultraviolet light B (NB-UVB); oral); photochemotherapy; photodynamic therapy; phototherapy; psoralen ultraviolet light A; psoriasis; pulsed dye laser; visible light
Mesh:
Year: 2019 PMID: 31351884 DOI: 10.1016/j.jaad.2019.04.042
Source DB: PubMed Journal: J Am Acad Dermatol ISSN: 0190-9622 Impact factor: 11.527